Leading Prostate Cancer Group Says New Drug Gives Hope To Men With Advanced Prostate Cancer

Prostate Conditions Education Council Applauds FDA Priority Review and ApprovalDENVER, Sept. 4, 2012 /PRNewswire-USNewswire/ — Leading prostate cancer group, the Prostate Conditions Education Council (PCEC), applauds the approval by the United States Food and Drug Administration (FDA) of a groundbreaking new therapy, Xtandi, formerly known as MDV3100. The drug has shown promise in clinical …

Posted in Uncategorized